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The aim of our study was to develop a method for
selection of subpopulations of insulin producing
RINm cells with higher resistance to beta cell toxins.
Cells, resistant to streptozotocin (RINmS) and
alloxan (RINmA), were obtained by repeated ex-
posure of parental RINm cells to these two toxins,
while the defense capacity was estimated by the
MTT colorimetric method, and [3H]-thymidine in-
corporation assay. We found that RINmS and
RINmA displayed higher resistance to both strepto-
zotocin (STZ) and alloxan (AL) when compared to
the parental RINm cells. In contrast, no differences
in sensitivity to hydrogen peroxide were found
between toxin selected and parental cells. Partial
protection from the toxic effect of STZ and AL was
obtained only in the parental RINm cells after
preincubation of cells with the unmetabolizable 3-
O-methyl-glucose. The possibility that GLUT-2 is
involved in cell sensitivity to toxins was confirmed
by Western blot analysis, which showed higher
expression of GLUT-2 in parental RINm compared
to RINmS and RINmA cells. In addition to the
higher cell defense property evidenced in the
selected cells, we also found higher insulin content
and insulin secretion in both RINmS and RINmA
cells when compared to the parental RINm cells. In
conclusion, STZ and AL treatment can be used for
selection of cell sub-populations with higher cell
defense properties and hormone production. The
different GLUT-2 expression in parental and re-
sistant cells suggest involvement of GLUT-2 in
mechanisms of cell response to different toxins.
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INTRODUCTION
Beta-cell lines constitute a potential source of
genetically engineered insulin-producing cells
for replacement of difficult-to-obtain human
tissue for pancreatic islet transplantation.1-3
Beta-cells are known to be susceptible to
destruction, primarily by toxins, autoimmune
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mechanisms, and by infectious agents, with sev-
eral features of the destructive process common
to all etiological factors.41
Alloxan (AL) was the first cytotoxic com-
pound reported to cause inhibition of glucose-
induced insulin secretion and selective beta-cell
damage,Isl but insulin deficiency can also be
induced by streptozotocin (STZ), which is a
glucose analog (glucopyranose, 2-deoxy-2-
[3-methyl-e-nitrosourido-D]) causing specific
beta-cell destruction.6 Both compounds cause
fragmentation of nuclear beta-cell DNA, poly
(ADP-ribose) polymerase activation, and
NAD+ depletion.4 The cytotoxic activity of
these compounds seems to be achieved through
their penetration into the beta-cells, a phenom-
enon which by itself depends on the expression
of the glucose transporter protein-2 (GLUT-2).
7,s An additional contributor to beta cell
sensitivity to various toxins related to their poor
antioxidant enzyme defense system. I91
Recently, STZ was found to induce cell
differentiation in pancreatic islets. Following
exposure of cells to STZ, PDX-1 positive beta-
stem cells differentiate into insulin-producing
cells.1 Beta-cell sensitivity to various toxins is
not homogeneous, neither in pancreatic islets
nor in tumor derived lines of insulin producing
cells. Major differences exist also between
human and rodent tissues, with rodents islet
cells being more sensitive to diabetogenic
toxins.[11’12] Beta-cell heterogeneity has also
been found at the level of glucose sensitivity
and intracellular insulin content.131
The RINm cell line which we used in the
present study, was established from a transplan-
table, radiation-induced rat islet cell tumor,TM a
cell line commonly used by many investigators
to study beta cell characteristics and function.
In the present study, we report on a method
for selection of toxin resistant cells, based on
repeated exposure of parental RINm cells to a
high dose of STZ and AL. This method allows
for selection of cells with improved defense
capacity and higher hormone production.
MATERIALS AND METHODS
Materials
Streptozotocin, alloxan, 3-O-methyl glucose (3-
OMG), C,N-diphenyl-Nt-4,5-dimethyl thiazol-2-
yl tetrazolium bromide (MTT), bovine serum
albumin and colchicine were purchased from
Sigma (St. Louis, Mo., USA) and [3HI thymidine
(2 Ci/mmol) was purchased from ICN Pharma-
ceutical, Inc. (Costa Mesa, Ca., USA). The RPMI
1640 culture medium, fetal calf serum (FCS),
penicillin, streptomycin, trypsin-EDTA solution
and other reagents were obtained from Biologi-
cal Industries Beit Haemek, Israel. Insulin RIA
was obtained from Sorin Biomedica (Saluggia,
Italy) and the rat insulin standards from LINCO
Research, Inc., (St. Louis, Mo., USA). The rabbit
anti-GLUT-2 antibody was purchased from
Chemicon, Inc., (Temecula, Ca., USA). A major
band on membrane preparation was recognized
at approximately 53-61 kDa. Peroxidase-labeled
anti-rabbit-IgG antibody from Jackson Labora-
tories, Inc. (West Grove, Pennsylvania, USA)
was used as a second antibody. The ECL detec-
tion system was purchased from Amersham
(Braunschweig, Germany) and the protein
molecular weight standards from GIBCO Life
Technologies (Vienna, Austria).
Cell Culture and Selection Procedure
The RINm cells, which have been previously
described in detail,TM were kindly provided
by M. Walker (Weizmann Institute of Science,
Rehovot, Israel). Cells were cultured in RPMI
1640 medium supplemented with 10% FCS, 2
mmol/1 L-glutamine, 100 IU penicillin and
100tg/ml streptomycin. Cells were grown in
plastic tissue culture flasks at 37C in 95%
humidified air with 5% CO2. Cells free of
micoplasma contamination were used in all
experiments. Resistant cell subpopulations were
obtained following repeated exposure of par-
ental RINm cells to STZ or AL. Briefly, cells wereRESISTANCE OF INSULIN-PRODUCING RINm CELLS 213
grown to near confluence in culture flasks and
then incubated for I hr in glucose-free Krebs-
Ringer bicarbonate buffer, supplemented with
10mM HEPES, bovine albumin 0.1% (KRB),
containing 10mM STZ. Following this proce-
dure, approximately 10% of the cells remain
attached to the flask wall. When these cells
reached semiconfluence upon culture, a second
STZ treatment was performed as described
above. A similar procedure was used with
20mM of AL in order to obtain an AL-resistant
cell subpopulation. In parallel, the control
parental RINm cells were incubated twice with
KRB alone. In this study we used only cells from
passages 14-22.
Determination of Cell Resistance
to STZ, AL and Hydrogen Peroxide
After exposure of the cells to various concentra-
tions of toxins, cell resistance was evaluated by
measurments of cell viability and proliferation.
Cell viability was determined by the MTT
colorimetric assay, which reflects mitochondrial
oxidative processes of living cells. [14] Briefly,
ceils were cultured for 3 days in 24-well plates
(2 x 105 cells/ml/well) and then exposed for 2
hr to a glucose-free KRB solution containing
various concentrations of STZ (0-10mmol/1) or
AL(0-10mmol/1). The STZ solution was re-
placed by KRB medium supplemented with
0.5mg/ml MTT for a period of 2 hr. The MTT-
containing medium was then removed, and
the cells were exposed to 2 ml isopropanol. The
reduction of tetrazolium salt to formazan was
quantified by measuring optical density with a
spectrophotometer at 540 nm. Cell proliferative
activity was determined by [3HI thymidine
incorporation assay. Cells (0.5 x 105/200tl/
well) were cultured for 24 hr in 96-well micro-
plates and then exposed for 2 hr to various
concentrations of STZ or AL and pulsed for 18 hr
with 1 Ci/well of [3HI thymidine. The cells
were harvested by the Micromate 196 instru-
ment (Packard, Switzerland), and the level of
incorporated [3H] thymidine was estimated
by counting scintillation radioactivity. Results
were expressed as percent of MTT reduction or
thymidine incorporation in the absence of
toxins. In order to estimate the toxic effect of
hydrogen peroxide which is a GLUT-2 indepen-
dent compound, the cells were exposed to 50
mol/1H202 for 20 and 60 min in Dulbeccols
phosphate-buffered saline, pH 7.4 at 37C.
The cells were then washed and cultivated in cul-
ture medium for 18hr with 1 tCi/well of [3H]
thymidine.
Effect of 3-OMG on STZ Toxicity
GLUT-2 involvement in beta-cell sensitivity to
toxins was indirectly estimated by preincubation
of parental RINm, RINmS and RINmA cells with
20mM of non-metabolizable 3-OMG for 30 min
prior to STZ and AL exposure. The expected
competitive inhibitory effect of 3-OMG on
cytotoxicity was determined by [3H] thymidine
incorporation assay.
Western Blot Analysis of GLUT-2
Membrane GLUT-2 pellets of parental and
resistant cells were resuspended in a sample
buffer as previously described. I151 Sixty tg of
total membrane protein/well were resolved in
10% SDS-polyacrylamide gel, with the vertical
mini-gel system MGV-100 (C.B.S. Scientific Co.,
USA). The protein was then electroblotted to
Hybond-ECL nitrocellulose membrane (Amer-
sham) at 22V for 1.20 h with the semi-dry blotter
EBU-4000 (C.B.S. Scientific Co.). The membrane
was washed for 30 min in PBS with 0.1% Tween-
20 (PBS-T) and then blocked overnight in PBS-T
with 5% non-fat dry milk at 4C. Following five
10-min washing steps in PBS-T, the membrane
was incubated with a rabbit anti-GLUT-2 anti-
body (1:5000 dilution), washed in PBS-T, the
membrane was incubated for I h with peroxi-
dase-labeled anti-rabbit-IgG antibody (1:10 000
dilution) in 5% milk PBS-T. The specific protein214 K.O. BLOCH et al.
bands were visualized by chemiluminescence
using ECL detection system.
Determination of Intracellular Insulin
Content and Secretion
Following trypsinization, the cells were har-
vested, counted, and their intracellular insulin
content was determined by radioimmunoassay
(RIA) after sonication for 15 seconds and acid
ethanol extraction of insulin. The level of insulin
secreted in to the culture medium (11mM of
glucose) was determined by RIA.
Determination of Cellular
Chromosome Number
Growing cells were treated with colchicine (0.25
tg/ml medium) for 1.5hr at 37C. Following
trypsin-EDTA treatment, detached cells were
centrifuged, pellet prepared and fixed by cold
methanol/acetic acid (3:1, vol./vol.). Chromo-
somes were spread by dropping the suspension
onto ice-cold microscope slides and allowed to
air dry. Preparations were stained with freshly
prepared Giemsa stain. The cell chromosome
number was determined by counting metaphases
of 1000 cell of each type.
Statistical Analysis
Analysis of variance (ANOVA) was utilized for
evaluation of the statistical significance of dif-
ferences between groups. The results are pre-
sented as mean values 4-SEM of independent,
repeated experiments. Experiments were done
in triplicate; p values < 0.05 were considered
significant.
RESULTS
Cell Resistance to Various Toxins
Higher cell viability following toxin treatment
was found in RINmS and RINmA than parental
RINm cells using both the MTT (Fig. 1) and
[3H]thymidine incorporation assay (Fig. 2). How-
ever, we did not find any differences in sen-
sitivity of parental and toxin selected cells to
hydrogen peroxide (Fig. 3). Because the [3H]
thymidine incorporation assay was significantly
more sensitive than the MTT method, we used
the radioactive assay in all experiments for
determining STZ and AL toxicity. As sensitivity
to STZ and AL depends on their penetration to
the cell and 3-OMG may reduce toxints penetra-
tion by blocking GLUT2,7"s we studied the
competitive effect of 3-OMG on the cell reaction
to toxin exposure.
Effect of 3-OMG on STZ and AL Toxicity
Incubation of the cells with the unmetabolized
sugar, 3-OMG (20 mM) prior to toxin treatment,
rendered the parental RINm ceils more resistant
to STZ (10mM) and AL (10mM) action, as
expressed by increased level of [3H] thymidine
incorporation. In contrast, RINmS and RINmA
sensitivity to STZ (10 mM) and AL (10 mM) was
not affected by this procedure (Fig. 4). These
data suggest that GLUT-2 level plays a role in
toxin accessibility to the cell.
Western Blot Analysis of GLUT-2
Using rabbit anti-GLUT-2 polyclonal antibody,
GLUT-2 protein was detected at 60 kDa in both
parental cells and toxin-selected cell subpopula-
tions. However, the level of GLUT-2 expression
was lower in RINmS and RINmA cells than that
found in the parental RINm cells (Fig. 5). The
possibility that poor GLUT-2 expression in the
selected cells would reduce the cell capacity to
produce insulin was then investigated.
Intracellular Insulin Content
and Secretion
Interestingly, the intracellular insulin con-
centration of RINmA and RINmS cells wasRESISTANCE OF INSULIN-PRODUCING RINm CELLS 215
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FIGURE 1 Viability (estimated byMTT assay) of RINm (black bar), RINmS (hatched bar) and RINmA (open bar) cells exposed
to STZ (A) and AL (B). Results are expressed as percent ofMTT reduction compared to control values (0 mM). Data are given as
mean values 4- SEM (n 3). *p < 0.05 compared to RINm cells.
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FIGURE 2 [3Hl thymidine incorporation in RINm (black bar), RINmS (hatched bar) and RINmA (open bar) cells exposured to
STZ (A) and AL (B). Results are expressed as percent of H] thymidine incorporation as compared to control (0 mM). Data are
given as mean values 4- SEM (n =3). *p < 0.05 compared to RINm cells.120
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FIGURE 3 [3H] thymidine incorporation in RINm (black circle) and RINmS (open circle) cells exposured to 50 mol/1 H202.
Results are expressed as percent of [3H] thymidine incorporation as compared to control (0 tmol/1). Data are given as mean
values & SEM (n 3).
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FIGURE 4 Effect of3-OMG on STZ (A) and AL (B) cytotoxicity as measured in the thymidine incorporation assay. Prior to STZ
or AL treatment (10mM), cells were incubated with 3-OMG (20mM) for 0.5hr. Black bars STZ or AL treatment alone, open
bars 3-OMG + drug. Values represent means + SE for 3 independent assays. *p < 0.05 compared to RINm cells incubated
with STZ or AL alone.RESISTANCE OF INSULIN-PRODUCING RINm CELLS 217
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FIGURE 5 Western blot analysis of GLUT-2 in parental RINm and toxin selected RINmS and RINmA cells. GLUT-2 protein
was detected by immunoblotting as described in MATERIALS AND METHODS, using 60g protein per lane. The GLUT-2
protein is demonstrated by a distinct band ( 60 Kda). The blot shown is representative of 3 independent experiments.
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FIGURE 6 Insulin content in RINm, RINmS and RINmA cells. Values represent means 4-SEM of 6 independent assays.
"p < 0.05 compared to RINm cells.
significantly higher (2.2 and 5.5-fold, respec-
tively) than in the parental RINm cells under
identical conditions (Fig. 6), suggesting intact
cell function. In addition, insulin released by
RINmA and RINmS (16.8 + 1.2 and 17.64-3.0
ng/24 h/106 cells, respectively) into the culture
medium (11mM of glucose) was approximately
2.5-times higher of that secreted by the parental
RINm cells (6.46 4- 0.7ng/24 h/106 cells).
Chromosome Number
Cytogenetic analysis of the chromosome number
indicated that the majority of parental as well as
STZ and AL selected cells, was composed of
hypodiploid cells with a chromosome number of
38 to 41 (2n 42). However, toxin selected cells
had a higher frequency of polyploid cells (1.5-
2.2%) than parental RINm cells (0.7%).218 K.O. BLOCH et al.
DISCUSSION
The defense properties of beta-cells are believed
to be crucial to their long-term survival after
transplantation. In the present study, we demon-
strated using two different methods, that selec-
tion of cell subpopulations with improved
defense mechanisms can be obtained upon
repeated exposure of tumoral insulin-producing
beta-cells to high doses of STZ and AL. The STZ
resistance obtained using this procedure, may
be explained by the direct relation between the
cytotoxic effect of this compound and the level
of GLUT-2 expression in the beta-cells. E71 Such a
relationship suggests that GLUT-2 involvement
in STZ cytotoxicity is associated with the specific
recognition of STZ as a transportable substrate.
Interestingly, no difference in sensitivity to
oxygen free radical donor, such as hydrogen
peroxide, was found between toxin selected and
parental cells, suggesting a different pathway of
cytotoxic activity then STZ and AL. The toxin-
based selection protected the surviving cells
from STZ as well as from AL. Our observation
that GLUT-2 mediates not only STZ but also AL
uptake into the beta-cells is supported in the
literature. Esl GLUT-2 is known to be the major
glucose transporter isoform expressed in rodent
[161 beta-cells. Therefore, it is possible that the cell
resistance obtained in RINmS and RINmA cells
was due to the selection of surviving cells with a
reduced expression of GLUT-2. Indeed, Western
blot analysis showed that the toxin-resistant RIN
cells when compared with parental ones ex-
pressed a lower level of GLUT-2 protein. More-
over, a competitive inhibition of STZ and AL
cytotoxicity by the unmetabolized 3-OMG could
be demonstrated only in parental RINm cells. 3-
OMG binds to and is transported by a pancreatic
beta-cell membrane glucose transporter, but it
is not metabolized in the beta-cell itself.5’81
Our results are in agreement with the reported
deficiency of GLUT-2 expression in pancreatic
islets isolated from multiple low-dose STZ-
treated mice.171 As 3-OMG did not confer
complete cell protection from STZ action, we
assume that additional factors, such as free
radical scavenging enzymes and repair genes,
are involved in cell defense mechanisms. In-
deed, our data indicate that the cytotoxic effect
of H202 is not influenced by the different GLUT-
2 expression of the two cell population in the
study, and a decrease in GLUT-2 expression, is
not thus expected to protect beta cells from
immune-mediated cell death. The finding that
the level of cellular insulin content and insulin
secretion in RINmS and RINmA was higher than
in the parental RINm cells, was unexpected,
particularly due to the finding of lower GLUT-2
in these subpopulations. Such insulin enrich-
ment of toxin-treated cells could have resulted
from the transition of this cell population to a
more differentiated stage. This suggestion is in
agreement with a recent demonstration differ-
entiating PDX-1 positive beta-stem cells into
insulin-producing cells following STZ injury.
STZ was found to induce expression of PDX-1
transcription factor in a population of somatos-
tatin-producing cells, which differentiated into
insulin-producing cells.I1 As RINm cell lines
are known to be composed not only of insulin,
but also of somatostatin-producing cells,TM this
latter cell population could act as a multi-
potential source for toxin-inducible, insulin-
producing cells. Transition of cells from a one
stage to another following toxin injury was also
demonstrated by the increased rate of cell poly-
ploidization, a phenomenon previously describ-
ed in pancreatic beta-cells of diabetic animals.ls
Our data suggest that STZ and AL treatment
can be used as a method for selection of toxin-
resistant subpopulations of RIN cells. Although
selected resistant cells obtained by this method
express a low level of GLUT-2, their functional
capacity as reflected by intracellular insulin
content and insulin secretion does not seem to
be impaired. Further investigation is needed in
order to elucidate the mechanisms leading to
this phenomenon and to evaluate its utility in
non-tumor-derived insulin-producing cells.RESISTANCE OF INSULIN-PRODUCING RINm CELLS 219
Such research would allow future transplanta-
tion of highly protected and functional insulin-
producing cells from various sources.
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